01/12/2012 11:54 EST | Updated 03/13/2012 05:12 EDT

Criteria for Saskatchewan MS patients to be part of U.S. liberation therapy trial

REGINA - Premier Brad Wall has announced that multiple sclerosis patients in Saskatchewan can apply to take part in a clinical trial of so-called liberation therapy in the United States. Deadline for applications is Feb. 24. The criteria:

— Must be between 18 and 60 years old.

— Must live in Saskatchewan.

— Must agree to comply with the clinical trial's research protocols.

— Must be able to travel between Canada and the United States.

— Must not be pregnant or planning to become pregnant within six months of entering the research study.

— Must not have had any changes in MS drug regimens in the six months prior to entering the research study.

— Must not have a known allergy to nickel, iodine or gadolinium-based contrast agents, which cannot be adequately pre-medicated

Applications can be made over the phone at 1-855-690-9901 or online. Go to

Source: Government of Saskatchewan